Cyclezyme appoints Stefan Lundström CEO of melanin unit MelaNova Bioscience

• Cyclezyme appointed Stefan Lundström CEO of newly formed subsidiary MelaNova Bioscience, created to develop and commercialize its biomimetic melanin patent.
• Lundström brings experience in CEO leadership, international business development, sales, brand building, capital raising, and market expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclezyme AB published the original content used to generate this news brief via Cision (Ref. ID: 202609091200BITN____UKPR__SV_20260909-BIT-8193-0) on September 09, 2026, and is solely responsible for the information contained therein.